De novo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival.
Mittelbronn M, Capper D, Bunz B, Dietz K, Goeppert B, Ajaaj R, Tabatabai G, Stubenvoll F, Schlaszus H, Merseburger AS, Becker R, Freudenstein D, Wick W, Weller M, Meyermann R, Simon P.
Mittelbronn M, et al. Among authors: capper d.
Neuropathol Appl Neurobiol. 2007 Jun;33(3):299-307. doi: 10.1111/j.1365-2990.2006.00820.x.
Neuropathol Appl Neurobiol. 2007.
PMID: 17493011